Style | Citing Format |
---|---|
MLA | Ahmadinejad M, et al.. "Evaluation of Clinical Characteristics and Outcomes of Chest Trauma Patients With Covid-19 Infection Undergoing Emergency Surgeries." Cardiovascular and Hematological Disorders - Drug Targets, vol. 23, no. 2, 2023, pp. 99-103. |
APA | Ahmadinejad M, Soltanian A, Pak H, Zolfaghari M, Ahmadinejad I (2023). Evaluation of Clinical Characteristics and Outcomes of Chest Trauma Patients With Covid-19 Infection Undergoing Emergency Surgeries. Cardiovascular and Hematological Disorders - Drug Targets, 23(2), 99-103. |
Chicago | Ahmadinejad M, Soltanian A, Pak H, Zolfaghari M, Ahmadinejad I. "Evaluation of Clinical Characteristics and Outcomes of Chest Trauma Patients With Covid-19 Infection Undergoing Emergency Surgeries." Cardiovascular and Hematological Disorders - Drug Targets 23, no. 2 (2023): 99-103. |
Harvard | Ahmadinejad M et al. (2023) 'Evaluation of Clinical Characteristics and Outcomes of Chest Trauma Patients With Covid-19 Infection Undergoing Emergency Surgeries', Cardiovascular and Hematological Disorders - Drug Targets, 23(2), pp. 99-103. |
Vancouver | Ahmadinejad M, Soltanian A, Pak H, Zolfaghari M, Ahmadinejad I. Evaluation of Clinical Characteristics and Outcomes of Chest Trauma Patients With Covid-19 Infection Undergoing Emergency Surgeries. Cardiovascular and Hematological Disorders - Drug Targets. 2023;23(2):99-103. |
BibTex | @article{ author = {Ahmadinejad M and Soltanian A and Pak H and Zolfaghari M and Ahmadinejad I}, title = {Evaluation of Clinical Characteristics and Outcomes of Chest Trauma Patients With Covid-19 Infection Undergoing Emergency Surgeries}, journal = {Cardiovascular and Hematological Disorders - Drug Targets}, volume = {23}, number = {2}, pages = {99-103}, year = {2023} } |
RIS | TY - JOUR AU - Ahmadinejad M AU - Soltanian A AU - Pak H AU - Zolfaghari M AU - Ahmadinejad I TI - Evaluation of Clinical Characteristics and Outcomes of Chest Trauma Patients With Covid-19 Infection Undergoing Emergency Surgeries JO - Cardiovascular and Hematological Disorders - Drug Targets VL - 23 IS - 2 SP - 99 EP - 103 PY - 2023 ER - |